Current Environment: Production

Infant Formula Recall

We are aware of an infant formula recall. Learn more >>

From the moment of diagnosis through long-term follow-up, you'll work with a team of compassionate professionals who are committed to your child's health and your family's well-being.

Pediatric Hematology/Oncology Leadership

David A. Williams, MD

Chief, Division of Hematology/Oncology, Boston Children’s Hospital; Associate Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute; Institute Physician

Leland Fikes Professor of Pediatrics, Harvard Medical School

Kimberly Stegmaier, MD

Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Co-Director, Hematologic Malignancy Center (Basic & Translational Research); Ted Williams Chair, Dana-Farber Cancer Institute

Professor of Pediatrics, Harvard Medical School

Andrew Place, MD, PhD

Vice President, Chief Medical Officer, Division of Hematology/Oncology Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Assistant Professor of Pediatrics, Harvard Medical School

Matthew M. Heeney, MD

Associate Chief, Hematology; Director, Sickle Cell Program

Associate Professor, Harvard Medical School

Jonathan Whiting, DNP, RN, NE-BC, CCRN-K

Vice President, Associate Chief Nurse; Nursing/Patient Care & Clinical Operations

Barbara Cuccovia, PhD, RN, BMTCN

Director of Nursing, Pediatric Oncology, Dana-Farber Cancer Institute